Pancreatic β-cell fate in subjects with COVID-19.
Journal
Journal of diabetes investigation
ISSN: 2040-1124
Titre abrégé: J Diabetes Investig
Pays: Japan
ID NLM: 101520702
Informations de publication
Date de publication:
Dec 2021
Dec 2021
Historique:
revised:
10
09
2021
received:
07
09
2021
accepted:
13
09
2021
pubmed:
17
9
2021
medline:
24
12
2021
entrez:
16
9
2021
Statut:
ppublish
Résumé
Two recent reports denoted the potential of SARS-CoV-2 to directly infect β-cells and the possible fate of β-cells under COVID-19. The fight against SARS-CoV-2 will continue to develop more effective therapeutic strategies for diabetes.
Identifiants
pubmed: 34529355
doi: 10.1111/jdi.13671
pmc: PMC8668054
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
2126-2128Informations de copyright
© 2021 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd.
Références
Science. 2020 Nov 13;370(6518):856-860
pubmed: 33082293
Cell Metab. 2020 Dec 1;32(6):1041-1051.e6
pubmed: 33207244
Cell Metab. 2020 Dec 1;32(6):1028-1040.e4
pubmed: 33207245
Science. 2020 Nov 13;370(6518):861-865
pubmed: 33082294
Cell Metab. 2021 Aug 3;33(8):1577-1591.e7
pubmed: 34081913
Cell. 2021 Jan 7;184(1):15-17
pubmed: 33338422
Nat Metab. 2021 Feb;3(2):149-165
pubmed: 33536639
Cell Metab. 2021 Aug 3;33(8):1565-1576.e5
pubmed: 34081912